- Home
- AVIR vs NCA Comparison
AVIR vs NCA Comparison
Compare AVIR & NCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- NCA
- Stock Information
- Founded
- AVIR 2012
- NCA 1987
- Country
- AVIR United States
- NCA United States
- Employees
- AVIR N/A
- NCA N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- NCA Investment Managers
- Sector
- AVIR Health Care
- NCA Finance
- Exchange
- AVIR Nasdaq
- NCA Nasdaq
- Market Cap
- AVIR 247.5M
- NCA 288.4M
- IPO Year
- AVIR 2020
- NCA N/A
- Fundamental
- Price
- AVIR $3.42
- NCA $8.46
- Analyst Decision
- AVIR Hold
- NCA
- Analyst Count
- AVIR 1
- NCA 0
- Target Price
- AVIR $6.88
- NCA N/A
- AVG Volume (30 Days)
- AVIR 556.5K
- NCA 59.6K
- Earning Date
- AVIR 02-26-2025
- NCA 01-01-0001
- Dividend Yield
- AVIR N/A
- NCA 3.92%
- EPS Growth
- AVIR N/A
- NCA N/A
- EPS
- AVIR N/A
- NCA N/A
- Revenue
- AVIR N/A
- NCA N/A
- Revenue This Year
- AVIR N/A
- NCA N/A
- Revenue Next Year
- AVIR N/A
- NCA N/A
- P/E Ratio
- AVIR N/A
- NCA N/A
- Revenue Growth
- AVIR N/A
- NCA N/A
- 52 Week Low
- AVIR $2.75
- NCA $7.77
- 52 Week High
- AVIR $4.60
- NCA $9.12
- Technical
- Relative Strength Index (RSI)
- AVIR 62.36
- NCA 36.66
- Support Level
- AVIR $3.19
- NCA $8.30
- Resistance Level
- AVIR $3.32
- NCA $8.46
- Average True Range (ATR)
- AVIR 0.13
- NCA 0.11
- MACD
- AVIR 0.04
- NCA -0.00
- Stochastic Oscillator
- AVIR 82.58
- NCA 28.07
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About NCA Nuveen California Municipal Value Fund
Nuveen California Municipal Value Fund Inc is a diversified closed-end management investment company. Its primary objective is to provide current income exempt from regular federal and California income taxes. The fund's secondary objective is to enhance portfolio value relative to the California municipal bond market by investing in tax-exempt California municipal securities that the Fund's investment adviser and/or the Fund's sub-adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.